Essential Facts About Cardinal Health

Large-cap Health Care company Cardinal Health has logged a -4.4% change today on a trading volume of 3,857,431. The average volume for the stock is 2,296,019.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. Based in Dublin, United States the company has 47,040 full time employees and a market cap of $25,167,316,992. Cardinal Health currently offers its equity investors a dividend that yields 1.8% per year.

The company is now trading -10.75% away from its average analyst target price of $115.93 per share. The 14 analysts following the stock have set target prices ranging from $96.0 to $134.0, and on average give Cardinal Health a rating of buy.

Over the last 52 weeks, CAH stock has risen 33.6%, which amounts to a 13.5% difference compared to the S&P 500. The stock's 52 week high is $116.04 whereas its 52 week low is $77.56 per share. Based on Cardinal Health's average net margin growth of inf% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023 205,012,000 261,000 0 100.0
2022 181,364,000 -933,000 -1 -inf
2021 162,467,000 611,000 0 100.0
2020 152,922,000 -3,696,000 -2 -300.0
2019 145,534,000 1,363,000 1 inf
2018 136,809,000 256,000 0
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.